1. Cao, Nan, Zhang, Fangmei, Yin, Jiang, Lin, Ying, Luo, Liyun. 2024. LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. In Oncogene, 43, 1714-1725. doi:10.1038/s41388-024-02996-4. https://pubmed.ncbi.nlm.nih.gov/38605214/
2. Abate, W, Alrammah, H, Kiernan, M, Tonks, A J, Jackson, S K. 2020. Lysophosphatidylcholine acyltransferase 2 (LPCAT2) co-localises with TLR4 and regulates macrophage inflammatory gene expression in response to LPS. In Scientific reports, 10, 10355. doi:10.1038/s41598-020-67000-x. https://pubmed.ncbi.nlm.nih.gov/32587324/
3. Lin, Yuhe, Zhang, Xin, Wang, Yihui, Yao, Wei. 2024. LPCAT2-mediated lipid droplet production supports pancreatic cancer chemoresistance and cell motility. In International immunopharmacology, 139, 112681. doi:10.1016/j.intimp.2024.112681. https://pubmed.ncbi.nlm.nih.gov/39068758/
4. Watanabe, Hiroyuki, Miyake, Kunio, Matsuoka, Tomokazu, Masuyama, Keisuke, Yamagata, Zentaro. 2020. LPCAT2 Methylation, a Novel Biomarker for the Severity of Cedar Pollen Allergic Rhinitis in Japan. In American journal of rhinology & allergy, 35, 631-639. doi:10.1177/1945892420983646. https://pubmed.ncbi.nlm.nih.gov/33356413/
5. Shindou, Hideo, Shiraishi, Seiji, Tokuoka, Suzumi M, Uezono, Yasuhito, Shimizu, Takao. 2017. Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 31, 2973-2980. doi:10.1096/fj.201601183R. https://pubmed.ncbi.nlm.nih.gov/28341636/